Purchase Order 75N93020P01004

This is a $21,710 firm-fixed-price purchase order awarded by the National Cancer Institute, a civilian agency under the Department of Health and Human Services, to Fluigent, Inc., a foreign-owned for-profit organization. The contract is for the delivery of an ARIA Automated Perfusion System, a specialized microfluidic equipment used in advanced scientific research, with a performance period ending on May 27, 2025. The award is not associated with any set-aside program. Fluigent, Inc. has an...

The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke awarded a Firm Fixed Price Purchase Order contract to Fluigent, Inc. (doing business as Fluigent Inc.), a foreign-owned, for-profit organization specializing in microfluidics. The $17,211.00 contract is for the provision of an ARIA Perfusion System and Pressure Generator needed for studying synaptic transmission. The contract is set to be completed by September...

<p>The National Institute of Biomedical Imaging and Bioengineering awarded a purchase order to Fluigent, Inc. for a multi-channel microfluidic system valued at $24,954.00 on September 14, 2018, with completion by December 13, 2018. The order carries firm fixed price terms and no small business set-aside. Work is performed in Lowell, Massachusetts.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Integra Biosciences Corp. valued at $19,999.21 on August 24, 2020, for COVID-19 research equipment. The order covers a VIAFLO 384 base unit, VIAFLO 96-channel pipetting head, and VIAFLO three-position stage. Performance occurs in Hudson, New Hampshire, with a completion date of September 23, 2020. The contract carries firm fixed-price terms and no small business set-aside.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Formulatrix, LLC for $11,881.44 on February 6, 2019, with ultimate completion on February 5, 2020. The order covers hardware and software maintenance on a firm fixed-price basis. Place of performance is Bedford, Massachusetts. No small business set-aside was applied.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Oroboros Instruments GMBH for $72,180.69 on July 27, 2018, for high-resolution fluorespirometry equipment. Performance is located in Austria. The order carries a firm fixed price structure with an ultimate completion date of August 3, 2018. No small business set-aside was applied.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Standard Biotools Inc. (doing business as Fluidigm) on September 16, 2019, with a ceiling value of $19,158.00. No set-aside was used. Performance is at Bethesda, Maryland. The order is firm fixed price. Ultimate completion is September 16, 2020.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Formulatrix, LLC for $12,910.21 on January 14, 2020, for maintenance service and hardware support with an NT8 plate copy option. Performance is at Waltham, Massachusetts, with completion by February 5, 2021. The contract is firm fixed price with no small business set-aside.</p>

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Covidien Sales LLC valued at $28,704.00 on April 30, 2021, for an EndoFlip 1 System, EndoFlip Localization Kit, Endo Catheter 8cm Nasal Tip, and EF-100 EndoFlip 1-year service plan. The order carries a firm fixed price and no set-aside designation. Place of performance is Mansfield, Massachusetts. The ultimate completion date is March 24, 2023. The procurement was driven by the need to de-obligate unexpended...

Fluent Biosciences Inc. was awarded a $14,146.70 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to provide unspecified services or products in support of the agency's infectious disease research programs. Performance will take place at Fluent's Watertown, Massachusetts facility over approximately six weeks concluding on September 30, 2023. No major subcontractors or set aside...